Nabriva Therapeutics PLC - ADR (NBRV) Stock Is Up 3.49% This Week: Buy, Hold, or Sell?

Friday, May 19, 2023 10:15 AM | InvestorsObserver Analysts

Mentioned in this article

Nabriva Therapeutics PLC - ADR (NBRV) Stock Is Up 3.49% This Week: Buy, Hold, or Sell?

Nabriva Therapeutics PLC - ADR (NBRV) stock is down -64.40% over the last 12 months, and the average rating from Wall Street analysts is a Strong Sell. InvestorsObserver’s proprietary ranking system, gives NBRV stock a score of 29 out of a possible 100.

That rank is primarily influenced by a short-term technical score of 21. NBRV's rank also includes a long-term technical score of 30.

NBRV has an Overall Score of 29. Find out what this means to you and get the rest of the rankings on NBRV!

See Full NBRV Report

What's Happening with NBRV Stock Today

Nabriva Therapeutics PLC - ADR (NBRV) stock has gained 7.23% while the S&P 500 is up 0.21% as of 9:34 AM on Friday, May 19. NBRV is up $0.12 from the previous closing price of $1.66 on volume of 11,007 shares. Over the past year the S&P 500 is higher by 7.85% while NBRV is down -64.40%. NBRV lost -$21.32 per share in the over the last 12 months. Click Here to get the full Stock Report for Nabriva Therapeutics PLC - ADR stock.